您的位置: 首页 > 农业专利 > 详情页

MODULATION THERAPEUTIQUE POUR TRAITER LES ANOMALIES DE GLYCEMIE, Y COMPRIS LE DIABETE DE TYPE 2, ET/OU POUR REDUIRE LES NIVEAUX D'HBA1C, ET SYSTEMES ET METHODES ASSOCIES
专利权人:
NEVRO CORP.
发明人:
BALDONI, DANIEL,PANNU, SATINDERPALL SINGH
申请号:
CA3095480
公开号:
CA3095480A1
申请日:
2019.03.29
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Systems and methods for treating a patient having a blood glucose abnormality, such as type 2 diabetes (T2D), using an electrical signal are disclosed. A representative method for treating a patient includes, based at least in part on a patient indication of a blood glucose abnormality, positioning at least one implantable signal delivery device proximate to a target location at the patient's spinal cord within a vertebral range of from about C8 to about T12. The method further includes directing an electrical signal to the target location via the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充